EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Financiere de Tubize's enterprise value is €4,325.13 Mil.
Financiere de Tubize's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €91.45 Mil. Therefore, Financiere de Tubize's EV-to-EBITDA for today is 47.30.
The historical rank and industry rank for Financiere de Tubize's EV-to-EBITDA or its related term are showing as below:
XBRU:TUB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 48.18
Current: 47.31
During the past 13 years, the highest EV-to-EBITDA of Financiere de Tubize was 48.18. The lowest was 0.00. And the median was 0.00.
XBRU:TUB's EV-to-EBITDA is ranked worse than 86.15% of 462
companies
in the Biotechnology industry
Industry Median: 9.55
vs XBRU:TUB: 47.31
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Financiere de Tubize EV-to-EBITDA Historical Data
The historical data trend for Financiere de Tubize's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Financiere de Tubize's EV-to-EBITDA
For the Biotechnology subindustry, Financiere de Tubize's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Financiere de Tubize's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Financiere de Tubize's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Financiere de Tubize's EV-to-EBITDA falls into.
Financiere de Tubize's current Enterprise Value is €4,325.13 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Financiere de Tubize's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €91.45 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Financiere de Tubize (XBRU:TUB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Financiere de Tubize's PE Ratio for today is calculated as:
Financiere de Tubize's share price for today is €95.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Financiere de Tubize's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €1.980.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Financiere de Tubize's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Financiere de Tubize (XBRU:TUB) Business Description
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBRU:TUB has been successfully added to your 